We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Aperture will advance APRTX-001 as a potential treatment for ALS and frontotemporal dementia, with possible expansion for use ...

A new pill for treating dementia is delivering promising "topline" results in early-stage clinical trials, according to a recent press release by its makers.

Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on ...

Lucid Capital analyst Elemer Piros initiated coverage of Passage Bio (PASG) with a Buy rating and $68 price target Passage Bio, which has ...

A top psychologist has warned that 79-year-old Donald Trump’s increasingly erratic behavior likely points toward a personality disorder being rapidly worsened by dementia. “When people develop ...